Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human phosphatase RET31, and variants thereof

Human phosphatase RET31, and variants thereof

US Patent 7358074 · Granted Apr 15, 2008

Estimated economic value: $38,376,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions monovalent for CD28 binding and methods of use2024
Methods of treating systemic lupus erythematosus using a domain antibody directe2024
Predictive peripheral blood biomarker for checkpoint inhibitors2024
Nucleic acids encoding antagonistic CD40 monoclonal antibodies2023
Methods of treating autoimmune disease using a domain antibody directed against 2022
Methods of treating systemic lupus erythematosus using a domain antibody directe2022
Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity2022
Antibody polypeptides that antagonize CD40L2021
Methods of treating immune diseases by administering antibody polypeptides that 2021
Compositions monovalent for CD28 binding and methods of use2021
Nucleic acids encoding antibody polypeptides that antagonize CD402020
Method of using antibody polypeptides that antagonize CD40 to treat IBD2019